Yanping Yuan

Title: Yanping Yuan: Innovator in Monoclonal Antibody Development

Introduction

Yanping Yuan is a notable inventor based in Suzhou, China. He has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. His work focuses on creating innovative solutions for treating diseases, including various types of tumors.

Latest Patents

Yanping Yuan holds a patent for a monoclonal antibody specifically binding to human and monkey CD38 antigens. This patent includes a detailed preparation method and various uses of the antibody. The monoclonal antibody comprises antigen complementarity-determining regions CDR1, CDR2, and CDR3 of both the light and heavy chain variable regions, with specific amino acid sequences outlined in SEQ ID NO: 3, 4, 5, 8, 9, and 10. This innovative antibody can be utilized in pharmaceutical compositions for treating tumors that express CD38, such as human myeloma and lymphoma.

Career Highlights

Throughout his career, Yanping Yuan has worked with several prominent companies in the biotechnology sector. Notably, he has been associated with Acroimmune Biotech Co., Ltd. and Acrolmmune Biopharmaceutical Co., Ltd. His experience in these organizations has contributed to his expertise in monoclonal antibody research and development.

Collaborations

Yanping Yuan has collaborated with various professionals in his field, including Hongqun Hu and Xiaoqi Song. These collaborations have enhanced his research efforts and have led to advancements in the development of therapeutic antibodies.

Conclusion

Yanping Yuan is a distinguished inventor whose work in monoclonal antibodies has the potential to impact cancer treatment significantly. His innovative approaches and collaborations continue to drive advancements in biotechnology.